Amyris, Inc.

102 articles with Amyris, Inc.

• Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed

  10/1/2020

  Amyris, Inc. announced that it is currently delivering samples to pharmaceutical companies of a sustainable and scalable alternative to shark-based vaccine adjuvants currently used in a number of vaccines, including those directed at influenza and COVID-19.

• Amyris to Provide Business Overview And Update On Current Affairs At H.C. Wainwright 22nd Annual Global Investment Conference Today

  9/14/2020

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo , President and Chief Executive Officer, will provide a business overview and update on current affa

• Amyris Responds To LAVVAN's Filing Of Lawsuit On September 10, 2020

  9/11/2020

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, responds to LAVVAN, Inc.'s (LAVVAN) press release related to its commencement of a lawsuit against Amyris, Inc. (Amyris) for patent

• Amyris to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020

  9/8/2020

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced that John Melo , President and Chief Executive Officer, will present during the H.C. Wainwright 22nd Annual Global I

• Amyris Scales First Fermentation-Based Cannabinoid

  9/1/2020

  Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced that it has successfully scaled up the commercial production of Cannabigerol leveraging its industrial fermentation process capability.

• Amyris, Inc. Reports Second Quarter 2020 Results

  8/6/2020

  Record Quarter for Consumer Brands with 3X Revenue Growth Lowest Cash Operating Expenses in Five Quarters $200 Million Private Placement Significantly Reduced Debt and Debt Servicing Expense   [06-August-2020]   EMERYVILLE, Calif. , Aug. 6, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and B

• Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application

  7/27/2020

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets and IDRI (Infectious Disease Research Institute) today announce the signing of a binding term sheet for a planned COVID-19 RNA (ribonucleic acid) vaccine technology program. The program combines IDRI's expertise in combating i

• Amyris Launches Plant-derived Sustainable Silica for Clean Beauty Applications

  7/15/2020

  Aprinnova, Inc., an Amyris, Inc. joint venture, the leading supplier of high performance, clean beauty ingredients is commercializing a plant-derived silica made from sugarcane ashes.

• Amyris Partners With AB Mauri North America To Reduce Sugar In Baking Products Using PURECANE™ Sweetener

  6/22/2020

  Amyris, Inc. (Nasdaq: AMRS), a leading biotechnology company in the Clean Health and Beauty markets and a top supplier of sustainable and natural ingredients, and AB Mauri North America ,

• Amyris Announces Closing Of $200 Million Private Placement

  6/10/2020

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the closing of its previously announced private investment in public equity (PIPE) in the Company.

• Amyris Raises $200 Million From Private Placement

  6/4/2020

  Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it has successfully executed a binding funding agreement with leading institutional investors to raise $200 million a

• Amyris Changes its 2020 Annual Meeting of Stockholders to Virtual Format

  5/15/2020

  Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, due to public health and safety concerns related to the COVID-19 pandemic, recommendations and orders fr

• Amyris Receives GRAS Validation by Medical Expert Panel for its New Health and Nutrition Ingredient

  5/14/2020

  Amyris, Inc. (Nasdaq:AMRS), a leading synthetic biotechnology company with leadership in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announces that its first health and nutrition ingredient received a validation by a unanimous Panel of Medical Experts as Gene

• Amyris, Inc. Reports First Quarter 2020 Results

  5/8/2020

  Sales Revenue Doubled Versus Prior Year Quarter Strong Gross Margin And Earnings Growth From Improved Sales Mix And Lower Costs Significantly Improved Balance Sheet From Reduced Debt

• Amyris To Host First Quarter 2020 Financial Results Conference Call On May 8

  5/4/2020

   Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biology solutions provider, owner of Clean Beauty consumer brands and provider of proprietary functional ingredients, today announced that the company will host a conference call for investors and analysts on Friday, May 8, 2020 at 6:00 a.m. PT ( 9:00 a.m. ET ) to discuss its first

• Amyris Experiences Very Strong Sales Start with Pipette Hand Sanitizer for the Whole Family

  4/13/2020

   Amyris Inc. today announced the full market launch and sales of its Pipette branded hand sanitizer

• Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products

  3/31/2020

  Amyris, Inc., a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced that initial production of its hand sanitizer has started with Allure Labs as its contract manufacturing and packaging partner.

• Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant

  3/26/2020

  Amyris, Inc. (Nasdaq:AMRS), a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it is launching a hand sanitizer to h

• Amyris to Participate in Fireside Chat at 32nd Annual Roth Conference on March 16, 2020

  3/10/2020

  Amyris, Inc. announced that management will be participating in a fireside chat at the 32nd Annual Roth Conference to be held March 15-17, 2020, at the Ritz-Carlton, in Dana Point, California.

• Amyris Discovers Major Breakthrough in CBD Delivery

  3/6/2020

  Amyris, Inc. (Nasdaq: AMRS), today presented clinical data showcasing the superiority of its natural sugarcane squalane (marketed and sold as Neossance Squalane) as a carrier of CBD versus other oils. In order for CBD to be effective in topical applications, skin penetration is a key factor